Mablink Bioscience is a biotechnology company.
Mablink Bioscience has raised $30.1M in total funding. The most recent round was Series A. The last funding was announced in October 2022.
Mablink Bioscience's investors include Sofinnova Partners, Crédit Agricole, Mérieux Equity Partners, Elaia, Fournier-Majoie.
Mablink Bioscience is headquartered in Lyon, France.
Mablink Bioscience is a biotechnology company.
Mablink Bioscience is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mablink Bioscience — Funding & Investors." VCBacked, October 14, 2022, https://www.vcbacked.co/company/mablink-bioscience. Accessed September 30, 2026.
VCBacked. (2022). Mablink Bioscience — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/mablink-bioscience
{{cite web |title=Mablink Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/mablink-bioscience |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated